Vaccine News and Research

Latest Vaccine News and Research

Tightening of Ebola care practice rules following survivor’s death

Guidelines for the safe care of Ebola patients are being looked over after a patient's death due to a second infection from Ebola.

1 Nov 2019

Study shows how measles virus causes immune amnesia

Over the last decade, evidence has mounted that the measles vaccine protects in not one but two ways: Not only does it prevent the well-known acute illness with spots and fever that frequently sends children to the hospital, but it also appears to protect from other infections over the long term.

31 Oct 2019

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Sometimes vaccines need a little help to protect people against infectious diseases.

31 Oct 2019

Researchers describe how malaria parasites prepare blueprint to attack humans

Within seconds after an infected mosquito bites, the malaria parasite navigates the host skin and blood vessels to invade the liver, where it will stay embedded until thousands of infected cells burst into the bloodstream, launching malaria's deadly blood-stage infection.

31 Oct 2019

MSU research team wins NIH grant to explore new way to study the gut's immune system

One day, instead of requiring a painful needle injection, vaccinating against a host of formerly fatal diseases could be as simple as swallowing a pill. But getting to that point means first gaining a better understanding of how the immune system works in the complex human gut, according to Montana State University researcher Diane Bimczok.

30 Oct 2019

New grant funds innovative approach to bladder cancer treatment

The San Antonio Medical Foundation has awarded Texas Biomedical Research Institute Professor Jordi B. Torrelles, Ph.D., with a $173,000 grant to study a modified Mycobacterium bovis Bacillus Calmette et Guérin (BCG) vaccine shown to have promise for treating bladder cancer.

30 Oct 2019

New TB vaccine: mid-phase trials confirm safety, long-term prevention

A new study published on October 29, 2019, in the New England Journal of Medicine, reports a new vaccine which could change the face of tuberculosis prevention. The disease kills 1.5 million people worldwide each year.

30 Oct 2019

Facebook takes social media into preventive health – but is it private?

Facebook’s (FB) new Preventive Health Tool has been set up to connect its users to resources and reminders for health assessments in three major areas – heart disease and stroke, cancer, and seasonal influenza – thus making it easier for FB fans to remember to look after their health as well.

29 Oct 2019

Pro-inflammatory protein could play key role in protecting against herpes virus

Researchers at the University of Arizona College of Medicine - Phoenix have discovered a function in a pro-inflammatory protein that could play an important part in improving current and future therapeutics for the herpes virus.

29 Oct 2019

Novel antibodies could provide a universal flu vaccine

Now, a new study published in the journal Science on October 25, 2019, reports on a set of three novel antibodies that bind to another type of viral cell surface antigen called neuraminidase (NA) that is necessary for viral replication.

28 Oct 2019

Wild polio virus strain 3 finally conquered say scientists

World Polio day is observed on the 24th of October. This year on the day officials announced that one of the three strains of the wild polio virus has been finally wiped out due to persistent vaccination efforts across the globe.

26 Oct 2019

Newly identified antibodies could lead to better treatments and vaccines for influenza

A newly identified set of three antibodies could lead to better treatments and vaccines against influenza, according to a paper published this week in Science.

25 Oct 2019

Researchers find antibody that may protect against wide range of lethal influenza viruses

A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.

25 Oct 2019

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

An analysis and related commentary published in Clinical Infectious Diseases today provide in-depth examination of the deplorable and dangerous conditions in U.S. immigrant detention centers where seven children have died in the last 10 months.

25 Oct 2019

Scientists make breakthrough in the hunt for new C. diff vaccine

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff).

25 Oct 2019

UAB physicians encourage everyone to get a flu shot between October and early November

The change of season in October and November brings in crisp, fall weather for the majority of the United States. Many begin to look toward the holiday season to come, but few think about the impending cold weather and subsequent sickness that pops up when winter arrives.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

Optimal implementation of existing, new interventions essential to end HIV pandemic

Optimal implementation of existing HIV prevention and treatment tools and continued development of new interventions are essential to ending the HIV pandemic, National Institutes of Health experts write in a commentary Clinical Infectious Diseases.

24 Oct 2019

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

A clinical trial in which healthy adults will be deliberately infected with influenza virus under carefully controlled conditions is recruiting volunteers at four Vaccine and Treatment Evaluation Units (VTEUs) supported by NIH's National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Universal influenza vaccine developed at Cornell is set for human clinical trials

A universal influenza vaccine with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.

24 Oct 2019

Vaccine News and Research

Latest Vaccine News and Research

Tightening of Ebola care practice rules following survivor’s death

Study shows how measles virus causes immune amnesia

OHSU receives $2.1 million to develop new vaccine additives for tropical viruses

Researchers describe how malaria parasites prepare blueprint to attack humans

MSU research team wins NIH grant to explore new way to study the gut's immune system

New grant funds innovative approach to bladder cancer treatment

New TB vaccine: mid-phase trials confirm safety, long-term prevention

Facebook takes social media into preventive health – but is it private?

Pro-inflammatory protein could play key role in protecting against herpes virus

Novel antibodies could provide a universal flu vaccine

Wild polio virus strain 3 finally conquered say scientists

Newly identified antibodies could lead to better treatments and vaccines for influenza

Researchers find antibody that may protect against wide range of lethal influenza viruses

New analysis provides insight into dangerous conditions in U.S. immigrant detention centers

Scientists make breakthrough in the hunt for new C. diff vaccine

UAB physicians encourage everyone to get a flu shot between October and early November

Flu antibody could be a key to better treatments for severe flu disease

Optimal implementation of existing, new interventions essential to end HIV pandemic

NIAID-supported clinical trial begins at four Vaccine and Treatment Evaluation Units

Universal influenza vaccine developed at Cornell is set for human clinical trials

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in